with the company presently valued at less than $150 million and the FDA stating that the device/machinery is substantially different from all others, it's safe to say that the patents alone would be worth more than $300 million to J&J , Google or OPKO right now.
This company is staffed with senior, experienced management and funded by many deep pocketed investors as well as mutual and institutional funds. This stock is presently controlled by insiders and large institutions representing over 90% of the float.
This company will double if not triple in the coming year. IMO. I welcome any constructive comments or insights , positive or negative.
if yahoo stats are right insiders and institutions own over 95% of TRXC stock. Here's the good part 26% of float is short. As may 10th approaches and the tide goes out it will be interesting to see who's naked.........
possibly to announce sales in Europe? It will be interesting to see why no big institutions have dumped yet. Maybe we are seeing margin players getting crushed, shots running strong and management playing it smart.
The FDA merely is saying is that they want to see more data to approve SURGIBOT, they did not reject concept, application, need, etc. management implied during last CC that things were happening in Europe , a few sales announced on May 10th would expose a lot of naked shorts. Insiders and institutions control over 90% of float. Although the FDA decision was not positive it is by no means the end of TRXC. This could bounce to $4-5ps with management announcing 1 machine sold and possible pending sales on May 10th CC , IMO.
trying to make lemonade on a day when lemons are being served. There is no upside, monetarly, when you've been scalped. If support does show up...................................................
and win approval. Frost et al will finance it. Opk will ultimately own the patent. Just my opinion. Can not wait to see how FDA was bought out by irsg to postpone approval and cast doubt about trxc. This is better than reality TV. Get TRUMP on the case, "it's a rigged game" will be the mantra.
I am becoming more convinced that the reason QFOR became public was for a payday for someone. This companies management has very little to no experience and/or knowledge on running a public company. It appears at the present time that management/insiders could take this company private at almost $.50 on the dollar. In my opinion it would be in the insiders best interest to take this company private using current revenue flows to finance it. Surprise's me that they do not. Disturbing that some competitor doesn't. Something doesn't add up with this company and the present, undervalued, stock price.
and doing some further DD I come to the same conclusion I did some quarters back. QFOR is selling at a substantial discount to its value. The problem that I see is that it will quite possibly be dead money for quarters to come. Management has stated that the lead time from contract signing to revenue generation is long. They outsource all client date thru India, not comforting to Gov't contracts and large companies. Management has also shown , IMO, to be slow when dealing with the investment community. The long gaps between contracts is also alarming. Perhaps the most telling aspect is the amount of work QFOR does gratis prior to revenue generation, a big flaw in business model. One that successful companies like Salesforce have dealt with and overcome.
QFOR can/could bounce with the signing of a few nice contracts but management needs to address revenue generation and lead times to get the investment community excited and investing. Something missing in last few CC calls is the talk management had regarding a reverse split or other actions they were considering a year or so ago to get stock price above pink sheet status, very disappointing. They still appear as though they are in over their heads at the moment not something one looks for in an investment. I guess that's why the SP is stuck in the $.30s rather than the $1. range.
Jay , positive earning ? really ? Encouraging CC ? , management is still addressing excuses not success's. They admitted that implementation lead times will eat up much of current contract times, ie no money , ETC. ETC.. This board does not seem that negative, compared to some others its tame , IMO. I PRESENTLY have a lot of time and money tied up in QFOR . IMO the last call raises some serious questions for the next few quarters as far as revenue generation goes. I am doing some additional DD to reaccess my time horizon and risk/reward position. I appreciate it when people represent opposing views that are based on facts. I agree bashing for the sake of bashing is just another form of BS.
in less than 90 days . TIC TOC TIC .....,,,,.....Sure is a lot of info and news coming from management , must be a prolonged quiet period.
in QFOR.s space is the ability to make money with sales. After listening to CC call I am left with the feeling that QFOR will be doing the heavy lifting of data gathering and organizing data but not monatising anything for years to come. Having seen what a smart management team did with a company like salesforce, making money while setting up programs and process.s for companies , Qfor seems to be doing the work for peanuts/gratis and expecting to get paid down the road. Recurring revenue streams are good but QFOR is doing all the heavy lifting and I question the ability to protect future revenue streams. From the contracts they have reported and the lead times they are claiming to implement programs and to start making money it appears that the contracts expire before they can monatise anything of substance. Another question is will big companies be comfortable with all of their confidential info being sent to some back water area of India or will they want most of their proprietary info handled in U.S.A. I know a lot of current government quotes/ contracts are not allowing outsourcing leaving the U.S.
I have been following QFOR for awhile now and every call seems to be something new that pushes off revenue sales growth and recurring revenue growth. We know the space is attractive but my question is can QFOR.s management play with the big boys or are they fast becoming a wannabe. It is strange that things have been improving, businesswise according to management, for the last few quarters yet the stock price , a reflection of investor confidence , has been going down.
I know , I have been in since IPO and have had to buy more than I planned averaging down. The fact is Sharma has a ton of $$$$$ riding on CGIX and a ton of incentive options , etc. and he still bought on the open market with Poppajohn.
An aside nobody is talking about is the reliance that some big Pharma companies are building on CGIX platforms. It's possible CGIX goes cash flow positive faster than expected.
in fairness it was an open market transaction. He has a lot of his comp tied up with the price of cgix stock if I remember correctly. Management could use a marketing/financial guy , IMO. But if Poppajohn still supports lets see were we go.
on the open market. According to SEC filings between 3/15 and 3/16 Poppajohn bought 100k shares and Sharma bought 1k on the open market. A start and a much needed vote of confidence in my opinion.
It's tax time and I get to revisit mela and reap my tax loss adjustment. The message board is still populated with the same personalities and management continues to grow more inept with each passing year. It's reassuring to know in this ever changing world that some things never change. My question regarding mela or strata or whatever now is " what happens first , do they go out of business or will my tax loss benefit play out?
Health and Happiness to all.
FDA approval of surgibot , I think TRXC will announce the sale of a European machine first. IMO , FDA approval is big but the creation of a revenue stream wouldbe/is of greater importance right now. Either way the next couple of weeks should be interesting.